Dietary and Sentinel Factors Leading to Hemochromatosis
Open accessThe DOI matches its Crossref record; 138 of the 140 references it cites were found in a registry or an index.
Abstract
Although hereditary hemochromatosis is associated with the mutation of genes involved in iron transport and metabolism, secondary hemochromatosis is due to external factors, such as intended or unintended iron overload, hemolysis-linked iron exposure or other stress-impaired iron metabolism. The present review addresses diet-linked etiologies of hemochromatosis and their pathogenesis in the network of genes and nutrients. Although the mechanistic association to diet-linked etiologies can be complicated, the stress sentinels are pivotally involved in the pathological processes of secondary hemochromatosis in response to iron excess and other external stresses. Moreover, the mutations in these sentineling pathway-linked genes increase susceptibility to secondary hemochromatosis. Thus, the crosstalk between nutrients and genes would verify the complex procedures in the clinical outcomes of secondary hemochromatosis and chronic complications, such as malignancy. All of this evidence provides crucial insights into comprehensive clinical or nutritional interventions for hemochromatosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Increased levels of luminal iron in the GI tract affects the composition of the gut microbiota, with an elevated level of enteropathogens and a decrease in the protective species Lactobacilli [40].”
From Oral Iron Supplementation—Gastrointestinal Side Effects and the Impact on the Gut Microbiota (2021) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650 · cited 1×
“In contrast, dietary iron deficiency decreases hepcidin production, leading to intestinal iron absorption and iron release from macrophages so that more iron is available for the body’s needs [10,71,72].”
BackgroundNrf2–Keap1 defines a physiologically important stress response mechanism
Motohashi, H., & Yamamoto, M. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.09.003 · Cited by 1,725 · cited 1×
“Following this, the NRF2/sMAF heterodimer is transported into nucleus and binds to ARE for gene induction [97,98].”
BackgroundHepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
Ganz, T. (2003) · Blood · doi:10.1182/blood-2003-03-0672 · Cited by 1,544 · cited 1×
“In contrast, dietary iron deficiency decreases hepcidin production, leading to intestinal iron absorption and iron release from macrophages so that more iron is available for the body’s needs [10,71,72].”
BackgroundDysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis
Makker, J., Hanif, A., Bajantri, B., & Chilimuri, S. (2015) · Case Reports in Gastroenterology · doi:10.1159/000373883 · Cited by 1,351
Redox- and non-redox-metal-induced formation of free radicals and their role in human disease
Valko, M., Jomova, K., Rhodes, C. J., Kuča, K., & Musílek, K. (2016) · Archives of Toxicology · doi:10.1007/s00204-015-1579-5 · Cited by 1,022
Hereditary Hemochromatosis — A New Look at an Old Disease
Pietrangelo, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031573 · Cited by 992
Regulation of cellular iron metabolism
Wang, J., & Pantopoulos, K. (2011) · Biochemical Journal · doi:10.1042/bj20101825 · Cited by 986 · cited 1×
“Iron is an essential metal nutrient required for all living organisms [1,2].”
BackgroundGlutathione Is a Key Player in Metal-Induced Oxidative Stress Defenses
Jozefczak, M., Remans, T., Vangronsveld, J., & Cuypers, A. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13033145 · Cited by 810
Regulation of Iron Metabolism by Hepcidin
Nemeth, E., & Ganz, T. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111303 · Cited by 756 · cited 2×
“However, the primary action of HFE protein is the regulation of the iron storage hormone hepcidin [10], suggesting that it is involved in regulating systemic iron absorption rather than local iron uptake mediated by transferrin receptor.”
BackgroundGutteridge, J. M. C. (1986) · FEBS Letters · doi:10.1016/0014-5793(86)80626-3 · Cited by 629 · cited 2×
“Mechanistically, the local deposition of an excess amount of iron induces toxicity via oxidative radical production and peroxidation of lipids and DNA in cells [132,133].”
BackgroundBridle, K. R., Frazer, D. M., Wilkins, S. J., Dixon, J. L., Purdie, D. M., Crawford, D. H., Subramaniam, V. N., Powell, L. W., Anderson, G. J., & Ramm, G. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12602-5 · Cited by 620
EASL clinical practice guidelines for HFE hemochromatosis
European Association for the Study of the Liver (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.001 · Cited by 587
IDIOPATHIC HEMOCHROMATOSIS, AN IRON STORAGE DISEASE: A. Iron Metabolism in Hemochromatosis
FINCH, S. C., & FINCH, C. A. (1955) · Medicine · doi:10.1097/00005792-195512000-00001 · Cited by 579
Ponka, P. (1997) · Blood · doi:10.1182/blood.v89.1.1 · Cited by 552
Ferritin and the response to oxidative stress
ORINO, K., LEHMAN, L., TSUJI, Y., AYAKI, H., TORTI, S. V., & TORTI, F. M. (2001) · Biochemical Journal · doi:10.1042/bj3570241 · Cited by 535 · cited 1×
“Imported ferrous Fe (II) ions need to be intracellularly stored by binding to ferritin, due to the toxicity of the free form [3].”
BackgroundZimmermann, M. B., Chassard, C., Rohner, F., N'Goran, E. K., Nindjin, C., Dostal, A., Utzinger, J., Ghattas, H., Lacroix, C., & Hurrell, R. F. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.004564 · Cited by 520 · cited 1×
“The epidemic investigation in the gut iron-overloaded population shows a significant reduction in the beneficial lactobacilli and increased levels of enteropathogens, such as Escherichia coli and Salmonella species [110].”
BackgroundA mutation in SLC11A3 is associated with autosomal dominant hemochromatosis
Njajou, O. T., Vaessen, N., Joosse, M., Berghuis, B., van Dongen, J. W. F., Breuning, M. H., Snijders, P. J. L. M., Rutten, W. P. F., Sandkuijl, L. A., Oostra, B. A., et al. (2001) · Nature Genetics · doi:10.1038/90038 · Cited by 492
Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration
Masaldan, S., Bush, A. I., Devos, D., Rolland, A. S., & Moreau, C. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.033 · Cited by 481
Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin
Tanigawa, S., Fujii, M., & Hou, D.-X. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.02.017 · Cited by 480
Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis
Pinnix, Z. K., Miller, L. D., Wang, W., D’Agostino, R., Kute, T., Willingham, M. C., Hatcher, H., Tesfay, L., Sui, G., Di, X., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001127 · Cited by 448
Yang, C., Zhang, X., Fan, H., & Liu, Y. (2009) · Brain Research · doi:10.1016/j.brainres.2009.05.009 · Cited by 443
The Molecular Mechanism of Hepcidin-mediated Ferroportin Down-Regulation
De Domenico, I., Ward, D. M., Langelier, C., Vaughn, M. B., Nemeth, E., Sundquist, W. I., Ganz, T., Musci, G., & Kaplan, J. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-01-0060 · Cited by 434
Iron, hemochromatosis, and hepatocellular carcinoma
Kowdley, K. V. (2004) · Gastroenterology · doi:10.1016/j.gastro.2004.09.019 · Cited by 391
Ferroportin-mediated iron transport: Expression and regulation
Ward, D. M., & Kaplan, J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.03.004 · Cited by 373
Hepcidin-Induced Endocytosis of Ferroportin Is Dependent on Ferroportin Ubiquitination
Qiao, B., Sugianto, P., Fung, E., del-Castillo-Rueda, A., Moran-Jimenez, M.-J., Ganz, T., & Nemeth, E. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.018 · Cited by 334 · cited 9×
“For instance, metals, such as zinc and cadmium, can activate the metal response element-binding transcription factor-1 (MTF-1), which can promote the expression of FPN-1 and metal efflux from the cells for protection [76].”
BackgroundInfluentialHarrison-Findik, D. D., Schafer, D., Klein, E., Timchenko, N. A., Kulaksiz, H., Clemens, D., Fein, E., Andriopoulos, B., Pantopoulos, K., & Gollan, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602098200 · Cited by 308
Pietsch, E. C., Chan, J. Y., Torti, F. M., & Torti, S. V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210664200 · Cited by 284
Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives
Elmberg, M., Hultcrantz, R., Ekbom, A., Brandt, L., Olsson, S., Olsson, R., Lindgren, S., Lööf, L., Stål, P., Wallerstedt, S., et al. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.035 · Cited by 273
Jiao, Y., Wilkinson, J., Di, X., Wang, W., Hatcher, H., Kock, N. D., D'Agostino, R., Knovich, M. A., Torti, F. M., & Torti, S. V. (2009) · Blood · doi:10.1182/blood-2008-05-155952 · Cited by 266 · cited 2×
“Exposure to dietary curcumin known as a biologically active iron chelator perturbs all parameters of iron metabolism, particularly in mice that are fed a low-iron diet and when the animals display a phenotype of iron deficiency anemia, including a decline in serum iron and decreased transferrin saturation [92].”
BackgroundCooksey, R. C., Jouihan, H. A., Ajioka, R. S., Hazel, M. W., Jones, D. L., Kushner, J. P., & McClain, D. A. (2004) · Endocrinology · doi:10.1210/en.2004-0392 · Cited by 253
Zacharski, L. R., Chow, B. K., Howes, P. S., Shamayeva, G., Baron, J. A., Dalman, R. L., Malenka, D. J., Ozaki, C. K., & Lavori, P. W. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn209 · Cited by 230
Harada, N., Kanayama, M., Maruyama, A., Yoshida, A., Tazumi, K., Hosoya, T., Mimura, J., Toki, T., Maher, J. M., Yamamoto, M., et al. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.02.001 · Cited by 226
Translational pathophysiology: a novel molecular mechanism of human disease
Cazzola, M., & Skoda, R. C. (2000) · Blood · doi:10.1182/blood.v95.11.3280 · Cited by 223
Zhou, Z. D., & Tan, E.-K. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0218-4 · Cited by 222
Iron chelation in the biological activity of curcumin
Jiao, Y., Wilkinson, J., Christine Pietsch, E., Buss, J. L., Wang, W., Planalp, R., Torti, F. M., & Torti, S. V. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.11.003 · Cited by 209
Smith, B. C., Grove, J., Guzail, M. A., Day, C. P., Daly, A. K., Burt, A. D., & Bassendine, M. F. (1998) · Hepatology · doi:10.1002/hep.510270631 · Cited by 203
Ståhl, A.-L., Sartz, L., & Karpman, D. (2011) · Blood · doi:10.1182/blood-2010-09-309161 · Cited by 198
Multiple regulations of Keap1/Nrf2 system by dietary phytochemicals
Qin, S., & Hou, D. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201501017 · Cited by 189
Ramyaa, P., krishnaswamy, R., & Padma, V. V. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.10.024 · Cited by 185
Liver fibrosis and inflammation. A review
Stalnikowitz, D. K., & Weissbrod, A. B. (2003) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32127-1 · Cited by 183
Classification and diagnosis of iron overload.
Piperno, A. (1998) · PubMed · Cited by 173
A comparison of enteropathogenic and enterohaemorrhagicEscherichia colipathogenesis
Spears, K. J., Roe, A. J., & Gally, D. L. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00119.x · Cited by 172
Dietary iron overload as a risk factor for hepatocellular carcinoma in black africans
Mandishona, E., MacPhail, P. A., Gordeuk, V. R., Kedda, M.-A., Paterson, A. C., Rouault, T. A., & Kew, M. C. (1998) · Hepatology · doi:10.1002/hep.510270614 · Cited by 170
Rodrigues, P. N. S., Vázquez-Dorado, S., Neves, J. V., & Wilson, J. M. (2006) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2006.02.005 · Cited by 169
Shiga Toxins and the Pathophysiology of Hemolytic Uremic Syndrome in Humans and Animals
Mayer, C. L., Leibowitz, C. S., Kurosawa, S., & Stearns-Kurosawa, D. J. (2012) · Toxins · doi:10.3390/toxins4111261 · Cited by 169
Normal iron metabolism and the pathophysiology of iron overload disorders.
Siah, C. W., Ombiga, J., Adams, L. A., Trinder, D., & Olynyk, J. K. (2006) · PubMed · Cited by 167
Bridle, K. R., Cheung, T., Murphy, T. L., Walters, M. M., Anderson, G. J., Crawford, D. H. G., & Fletcher, L. M. (2006) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00002.x · Cited by 165
Relationship between the hemolytic action of heavy metals and lipid peroxidation
Ribarov, S. R., & Benov, L. C. (1981) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(81)90102-4 · Cited by 160
Gordeuk, V., McLaren, C., MacPhail, A., Deichsel, G., & Bothwell, T. (1996) · Blood · doi:10.1182/blood.v87.8.3470.bloodjournal8783470 · Cited by 154 · cited 1×
“It was also consistent with other observations in Africans that consider the confounding effects of viral infections [129,130].”
ResultReduction in Antioxidant Defenses may Contribute to Ochratoxin A Toxicity and Carcinogenicity
Cavin, C., Delatour, T., Marin-Kuan, M., Holzhauser, D., Higgins, L., Bezencon, C., Guignard, G., Junod, S., Richoz-Payot, J., Gremaud, E., et al. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl169 · Cited by 154
Saleem, K., Wani, W. A., Haque, A., Lone, M. N., Hsieh, M., Jairajpuri, M. A., & Ali, I. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.12.201 · Cited by 152
Pathology of dietary carbonyl iron overload in rats.
Park, C. H., Bacon, B. R., Brittenham, G., & Tavill, A. S. (1987) · PubMed · Cited by 151
Ross, S. L., Tran, L., Winters, A., Lee, K.-J., Plewa, C., Foltz, I., King, C., Miranda, L. P., Allen, J., Beckman, H., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.017 · Cited by 145 · cited 1×
“Mechanistically, FPN-1 is internalized without phosphorylation in response to hepcidin binding [77].”
BackgroundCancer risk following primary hemochromatosis: A population‐based cohort study in Denmark
Hsing, A. W., McLaughlin, J. K., Olsen, J. H., Mellemkjar, L., Wacholder, S., & Fraumeni, J. F. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600204 · Cited by 145
Afonyushkin, T., Oskolkova, O. V., Philippova, M., Resink, T. J., Erne, P., Binder, B. R., & Bochkov, V. N. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.204354 · Cited by 143
Serum Ferritin during Infection: A Longitudinal Study
Blrgegård, G., Hålxgren, R., KILLANDER, A., Strömberg, A., Venge, P., & WIDE, L. E. (1978) · Scandinavian Journal of Haematology · doi:10.1111/j.1600-0609.1978.tb00374.x · Cited by 143
The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C
Kazemi-Shirazi, L., Datz, C., Maier-Dobersberger, T., Kaserer, K., Hackl, F., Polli, C., Steindl, P. E., Penner, E., & Ferenci, P. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70236-2 · Cited by 141
Induction of FPN1 transcription by MTF-1 reveals a role for ferroportin in transition metal efflux
Troadec, M.-B., Ward, D. M., Lo, E., Kaplan, J., & De Domenico, I. (2010) · Blood · doi:10.1182/blood-2010-04-278614 · Cited by 136
Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans
Beutler, E., Barton, J. C., Felitti, V. J., Gelbart, T., West, C., Lee, P. L., Waalen, J., & Vulpe, C. D. (2003) · Blood Cells Molecules and Diseases · doi:10.1016/s1079-9796(03)00165-7 · Cited by 135
Limonciel, A., & Jennings, P. (2014) · Toxins · doi:10.3390/toxins6010371 · Cited by 132
Association Between Hemochromatosis (HFE) Gene Mutation Carrier Status and the Risk of Colon Cancer
Shaheen, N. J., Silverman, L. M., Keku, T., Lawrence, L. B., Rohlfs, E. M., Martin, C. F., Galanko, J., & Sandler, R. S. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.2.154 · Cited by 131
Pietrangelo, A. (2004) · Hepatology · doi:10.1002/hep.20007 · Cited by 128
Horiguchi, H., Oguma, E., & Kayama, F. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr100 · Cited by 126
Emerging Enterohaemorrhagic Escherichia coli, Causes and Effects of the Rise of a Human Pathogen
Beutin, L. (2006) · Journal of Veterinary Medicine Series B · doi:10.1111/j.1439-0450.2006.00968.x · Cited by 121
Wang, J., Chen, G., Muckenthaler, M., Galy, B., Hentze, M. W., & Pantopoulos, K. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.954-965.2004 · Cited by 118
Kaltwasser, J. P., Werner, E., Schalk, K., Hansen, C., Gottschalk, R., & Seidl, C. (1998) · Gut · doi:10.1136/gut.43.5.699 · Cited by 118
Patterns of iron storage in dietary iron overload and idiopathic hemochromatosis.
Brink, B., Disler, P. B., Lynch, S., Jacobs, P., Rw, C., & Bothwell, T. H. (1976) · PubMed · Cited by 116
Wang, Q., Du, F., Qian, Z.-M., Ge, X. H., Zhu, L., Yung, W. H., Yang, L., & Ke, Y. (2008) · Endocrinology · doi:10.1210/en.2007-1626 · Cited by 114
Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis
Jiang, J., Chen, X., Ren, Z., & Zheng, S. (2018) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2018.11.002 · Cited by 107
Stachurska, A., Cieśla, M., Kozakowska, M., Wolffram, S., Boesch, C., Rimbach, G. H., Józkowicz, A., Dulak, J., & Łoboda, A. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200456 · Cited by 106
Iron Regulatory Proteins Mediate Host Resistance to Salmonella Infection
Nairz, M., Ferring-Appel, D., Casarrubea, D., Sonnweber, T., Viatte, L., Schroll, A., Haschka, D., Fang, F. C., Hentze, M. W., Weiss, G., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.06.017 · Cited by 103 · cited 1×
“However, activation of IRP by Salmonella infection can promote host innate immunity by inducing expression of antimicrobial proteins such as lipocalin 2 [91].”
BackgroundPietrangelo, A. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-923316 · Cited by 102
Bacteriophage lambda: alive and well and still doing its thing
Friedman, D. I., & Court, D. L. (2001) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00189-2 · Cited by 101
Banner, W., & Tong, T. G. (1986) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)35010-6 · Cited by 99
Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice
Utzschneider, K. M., & Kowdley, K. V. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.241 · Cited by 94
Gordeuk, V. R. (2002) · Seminars in Hematology · doi:10.1053/shem.2002.35636 · Cited by 93
S-Nitrosylation of IRP2 Regulates Its Stability via the Ubiquitin-Proteasome Pathway
Kim, S., Wing, S. S., & Ponka, P. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.1.330-337.2004 · Cited by 87
Trichothecene-induced hemolysis
Segal, R., Milo-Goldzweig, I., Joffe, A. Z., & Yagen, B. (1983) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(83)90152-7 · Cited by 78
Porphyrin and iron metabolism in sideroblastic anemia,.
Bottomley, S. S. (1977) · PubMed · Cited by 74
The hemolytic activity of deoxynivalenol and T‐2 toxin
Rizzo, A. F., Atroshi, F., Hirvi, T., & Saloniemi, H. S. (1992) · Natural Toxins · doi:10.1002/nt.2620010209 · Cited by 73
Gutteridge, J. M. C., & Xiao-Chang, F. (1981) · FEBS Letters · doi:10.1016/0014-5793(81)80022-1 · Cited by 72
Ochratoxin A impairs Nrf2‐dependent gene expression in porcine kidney tubulus cells
Boesch‐Saadatmandi, C., Wagner, A. E., Graeser, A. C., Hundhausen, C., Wolffram, S., & Rimbach, G. (2009) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/j.1439-0396.2008.00838.x · Cited by 69
The Relationship Between Body Iron Status, Iron Intake And Gestational Diabetes
Fu, S., Li, F., Zhou, J., & Liu, Z. (2016) · Medicine · doi:10.1097/md.0000000000002383 · Cited by 68
Harrison, S. A., & Bacon, B. R. (2005) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.08.005 · Cited by 66
Hemochromatosis after prolonged oral iron therapy in a patient with chronic hemolytic anemia
Wallerstein, R. O., & Robbins, S. L. (1953) · The American Journal of Medicine · doi:10.1016/0002-9343(53)90024-2 · Cited by 65
von Drygalski, A., & Adamson, J. W. (2013) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607112459648 · Cited by 60
Hepatic cirrhosis and hemochromatosis in three horses
Pearson, E. G., Hedstrom, O. R., & Poppenga, R. H. (1994) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.1994.204.07.1053 · Cited by 59
Human macrophage ferroportin biology and the basis for the ferroportin disease
Sabelli, M., Montosi, G., Garuti, C., Caleffi, A., Oliveto, S., Biffo, S., & Pietrangelo, A. (2017) · Hepatology · doi:10.1002/hep.29007 · Cited by 58
Iron Increases Diabetes-Induced Kidney Injury and Oxidative Stress in Rats
Gao, W., Li, X., Gao, Z., & Li, H. (2014) · Biological Trace Element Research · doi:10.1007/s12011-014-0021-9 · Cited by 58
Inherited Hfe–Unrelated Hemochromatosis in Italian Families
Camaschella, C., Fargion, S., Sampietro, M., Roetto, A., Bosio, S., Garozzo, G., Arosio, C., & Piperno, A. (1999) · Hepatology · doi:10.1002/hep.510290509 · Cited by 57
Tanaka, Y., Ikeda, T., Yamamoto, K., Ogawa, H., & Kamisako, T. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07180.x · Cited by 53
African iron overload and hepatocellular carcinoma (HA‐7–0–080)
Moyo, V. M., Makunike, R., Gangaidzo, I. T., Gordeuk, V. R., McLaren, C. E., Khumalo, H., Saungweme, T., Rouault, T., & Kiire, C. F. (1998) · European Journal of Haematology · doi:10.1111/j.1600-0609.1998.tb00993.x · Cited by 53
Mysterious link between iron overload and CDKN2A/2B
Toyokuni, S. (2010) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.11-001fr · Cited by 53
Genetic modification of iron metabolism in mice affects the gut microbiota
Buhnik-Rosenblau, K., Moshe-Belizowski, S., Danin-Poleg, Y., & Meyron-Holtz, E. G. (2012) · BioMetals · doi:10.1007/s10534-012-9555-5 · Cited by 53
Iron overload exacerbates age-associated cardiac hypertrophy in a mouse model of hemochromatosis
Sukumaran, A., Chang, J., Han, M., Mintri, S., Khaw, B., & Kim, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-05810-2 · Cited by 53
High Incidence of Extrahepatic Carcinomas in Idiopathic Hemochromatosis
Ammann, R. W., Müller, E., Bansky, J., Schüler, G., & Häcki, W. H. (1980) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528009181523 · Cited by 52
Systemic effects of topical application of T-2 toxin in mice
Schiefer, H. B., & Hancock, D. S. (1984) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(84)90350-8 · Cited by 51
Mitochondrial damage and iron metabolic dysregulation in hepatitis C virus infection
Hino, K., Nishina, S., Sasaki, K., & Hara, Y. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.044 · Cited by 50
Activation of the Nrf2-ARE pathway by the Alternaria alternata mycotoxins altertoxin I and II
Jarolim, K., Favero, G. D., Pahlke, G., Dostal, V., Zimmermann, K., Heiß, E. H., Ellmer, D., Stark, T. D., Hofmann, T. F., & Marko, D. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1726-7 · Cited by 48
Embryotoxicity Caused by DON-Induced Oxidative Stress Mediated by Nrf2/HO-1 Pathway
Yu, M., Chen, L., Peng, Z., Wang, D., Song, Y., Wang, H., Yao, P., Yan, H., Nussler, A. K., Liu, L., et al. (2017) · Toxins · doi:10.3390/toxins9060188 · Cited by 48
Mendes, A. I., Ferro, A., Martins, R., Picanço, I., Gomes, S., Cerqueira, R. M., Correia, M. A., Nunes, A. R., Esteves, J., Fleming, R., et al. (2008) · Annals of Hematology · doi:10.1007/s00277-008-0572-y · Cited by 47
Complement in Typical Hemolytic Uremic Syndrome
Orth‐Höller, D., & Würzner, R. (2010) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0030-1262883 · Cited by 45
Ilbäck, N., Frisk, P., Tallkvist, J., Gadhasson, I.-L., Blomberg, J., & Friman, G. (2008) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2007.12.001 · Cited by 43
Puchała, M., Szweda‐Lewandowska, Z., & Kiefer, J. (2004) · Journal of Radiation Research · doi:10.1269/jrr.45.275 · Cited by 43
Selective iron deposition in pancreatic islet B cells of transfusional iron‐overloaded autopsy cases
Lu, J., & Hayashi, K. (1994) · Pathology International · doi:10.1111/j.1440-1827.1994.tb02592.x · Cited by 43
Hepatocellular carcinoma and African iron overload.
Gangaidzo, I. T., & Gordeuk, V. R. (1995) · Gut · doi:10.1136/gut.37.5.727 · Cited by 42
When less is more: novel mechanisms of iron conservation
Bayeva, M., Chang, H., Wu, R., & Ardehali, H. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.07.003 · Cited by 41
[Secondary hemochromatosis in polytransfused patients with myelodysplastic syndromes].
Jaeger, M., Aul, C., Söhngen, D., Germing, U., & Schneider, W. (1992) · PubMed · Cited by 39
Yu, M., Peng, Z., Liao, Y., Wang, L., Li, D., Qin, C., Hu, J., Wang, Z., Cai, M., Cai, Q., et al. (2019) · Toxicon · doi:10.1016/j.toxicon.2019.02.018 · Cited by 39
Changed iron regulation in scrapie-infected neuroblastoma cells
Fernaeus, S. Z., Hälldin, J., Bedecs, K., & Land, T. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.10.018 · Cited by 38
Cirrhosis in Hemochromatosis: Independent Risk Factors in 368 HFE p.C282Y Homozygotes
Barton, J. C., McLaren, C. E., Chen, W., Ramm, G. A., Anderson, G. J., Powell, L. W., Subramaniam, V. N., Adams, P. C., Phatak, P. D., Gurrin, L. C., et al. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0012.3169 · Cited by 38
Tiniakos, G., & Williams, R. L. (1988) · PubMed · Cited by 37
Chen, J., Shi, Y., & Li, M. (2008) · Archives of Toxicology · doi:10.1007/s00204-008-0297-7 · Cited by 36
Ko, H. C., Maymani, H., & Hernandez, C. M. R. (2016) · Journal of Medical Case Reports · doi:10.1186/s13256-016-0970-z · Cited by 34
Kasvosve, I., Gangaidzo, I., Gomo, Z., & Gordeuk, V. (2000) · Acta Clinica Belgica · doi:10.1080/17843286.2000.11754276 · Cited by 33
Hemolytic Effects of Sodium Selenite and Mercuric Chloride in Human Blood
Brandão, R., de Lara, F. S., Pagliosa, L. B., Soares, F. A. A., da Rocha, J. B. T., Nogueira, C. W., & Farina, M. (2005) · Drug and Chemical Toxicology · doi:10.1080/01480540500262763 · Cited by 32
Characterisation of hemolysis induced by T-2 toxin
Gyöngyössy‐Issa, M. I. C., Khanna, V., & Khachatourians, G. G. (1985) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(85)90086-8 · Cited by 32
Species-specific hemolysis of erythrocytes by T-2 toxin
DeLoach, J. R., Gyöngyössy‐Issa, M. I. C., & Khachatourians, G. G. (1989) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(89)90059-8 · Cited by 32
Kim, B.-H., Jun, Y.-C., Jin, J.-K., Kim, J.-I., Kim, N.-H., Leibold, E. A., Connor, J. R., Choi, E., Carp, R. I., & Kim, Y. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.05.061 · Cited by 31
Friis, H., Range, N. S., Kristensen, C. B., Kæstel, P., Changalucha, J. M., Malenganisho, W. L. M., Krarup, H. B., Magnussen, P., & Andersen, Å. B. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114508162122 · Cited by 29
The Myths and Realities of Hemochromatosis
Beaton, M. D., & Adams, P. C. (2007) · Canadian Journal of Gastroenterology · doi:10.1155/2007/619401 · Cited by 27
Gyöngyössy‐Issa, M. I. C., & Khachatourians, G. G. (1985) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(85)90087-4 · Cited by 26
Deugnier, Y., Morçet, J., Lainé, F., Hamdi‐Rozé, H., Bollard, A.-S., Guyader, D., Moirand, R., & Bardou‐Jacquet, E. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.009 · Cited by 26
Identification and Characterisation of an Iron-Responsive Candidate Probiotic
Bailey, J. R., Probert, C. S. J., & Cogan, T. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026507 · Cited by 25 · cited 1×
“Moreover, in vitro evaluation suggested that that the iron supplementation increases the growth rate and health benefits of some lactobacillus strains [112].”
BackgroundHemochromatosis case definition: out of focus?
Adams, P. C. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0465 · Cited by 21
Nanba, S., Ikeda, F., Baba, N., Takaguchi, K., Senoh, T., Nagano, T., Seki, H., Takeuchi, Y., Moritou, Y., Yasunaka, T., et al. (2015) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2015-203215 · Cited by 21
Measurements of iron status and survival in African iron overload.
MacPhail, A. P., Em, M., Bloom, P. D., Paterson, A. C., Rouault, T. A., & Gordeuk, V. (1999) · PubMed · Cited by 20
Funakoshi, N., Chaze, I., Alary, A., Tachon, G., Cunat, S., Giansily‐Blaizot, M., Bismuth, M., Larrey, D. G., Pageaux, G., Schved, J., et al. (2015) · Liver International · doi:10.1111/liv.12984 · Cited by 17
Ferritin levels throughout childhood and metabolic syndrome in adolescent stage
Suárez‐Ortegón, M. F., Blanco, E., McLachlan, S., Fernández‐Real, J. M., Burrows, R. A., Wild, S. H., Lozoff, B., & Gahagan, S. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.11.008 · Cited by 16
Integrated stress response-altered pro-inflammatory signals in mucosal immune-related cells
Park, S., & Moon, Y. (2012) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2012.742535 · Cited by 15
Self-citationHereditary hemochromatosis and cancer risk: More fuel to the fire?
Mallory, M. A., & Kowdley, K. V. (2001) · Gastroenterology · doi:10.1016/s0016-5085(01)70014-5 · Cited by 13
Wang, X., Wang, L., & Liu, S. (2015) · Chemical Research in Toxicology · doi:10.1021/tx500422q · Cited by 12 · cited 1×
“As a counteracting response to metal influx in the circulation, treatment with heavy metals, such as lead, can enhance the production of hepcidin and consequent sequestering of splenic irons, resulting in reduced iron availability for erythropoiesis and metal-induced hemolytic anemia in severe cases [50].”
Secondary haemochromatosis in a patient with thalassemia intermedia.
Rotaru, I., Găman, A. M., & Gámán, G. (2014) · PubMed Central · doi:10.12865/chsj.40.01.13 · Cited by 12
Moon, Y. (2011) · Toxicon · doi:10.1016/j.toxicon.2011.11.010 · Cited by 12
Self-citationPeng, C., Chow, K., Chang, W., Tsai, C., Lin, T., Lin, S., & Chiu, C.-F. (1999) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199908)61:4<262::aid-ajh7>3.0.co;2-b · Cited by 9
Oh, C., Park, S., Kim, J., & Moon, Y. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.722520 · Cited by 8
Self-citation
Cited by
Rusu, I. G., Suharoschi, R., Vodnar, D. C., Pop, C. R., Socaci, S. A., Vulturar, R., Istrati, M., Moroșan, I., Fărcaș, A. C., Kerezsi, A. D., et al. (2020) · Nutrients · doi:10.3390/nu12071993 · Cited by 185
“In terms of genetics, different types of hereditary hemochromatosis are caused by mutations in the HFE, hepcidin (HAMP), hemojuvelin (HJV), ferroportin (SLC40)A1, and transferrin receptor 2 (TfR2) genes that correspond to genetic disorders of iron overload [63,64].”
BackgroundOral Iron Supplementation—Gastrointestinal Side Effects and the Impact on the Gut Microbiota
Bloor, S. R., Schutte, R., & Hobson, A. R. (2021) · Microbiology Research · doi:10.3390/microbiolres12020033 · Cited by 117
“Increased levels of luminal iron in the GI tract affects the composition of the gut microbiota, with an elevated level of enteropathogens and a decrease in the protective species Lactobacilli [40].”
BackgroundTako, E. (2019) · Nutrients · doi:10.3390/nu11112823 · Cited by 61
Scientific opinion on the tolerable upper intake level for iron
EFSA Panel on Nutrition, N. F. A. F. A. (., Turck, D., Bohn, T., Castenmiller, J. J. M., Henauw, S. D., Hirsch‐Ernst, K. I., Knutsen, H. K., Maciuk, A., Mangelsdorf, I., McArdle, H. J., et al. (2024) · EFSA Journal · doi:10.2903/j.efsa.2024.8819 · Cited by 57
Pattan, V., Villacreses, M. M. C., Karnchanasorn, R., Chiu, K. C., & Samoa, R. A. (2021) · Nutrients · doi:10.3390/nu13114044 · Cited by 19
Metadata
- Authors
- Oh, C.-K., & Moon, Y.
- Affiliations
- Pusan National University (KR)
- Corresponding author
- Moon, Yuseok
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-05-10
- Volume
- 11
- Issue
- 5
- Pages
- 1047
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6566178
- OpenAlex
- W2944615073
- Cited by
- 12
- References
- 140
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 1 · 2021: 4 · 2020: 1 · 2019: 1
- FWCI
- 0.24
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation of Korea (2018R1D1A3B05041889)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- secondary hemochromatosis, iron overload, diet, iron metabolism, gene-nutrient interactions, iron transport genes, hemolysis, cancer risk, dietary intervention
- MeSH terms
- Gene Expression Regulation, Hemochromatosis, Humans, Iron, Mutation, Iron, Dietary, Iron-Regulatory Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.